- Rockley successfully demonstrated the prediction of blood
pressure with strong intra-subject tracking using a laser-based
signal and without using demographic information
- Frequent monitoring of blood pressure changes is critical for
many applications including health, wellness, and fitness, high
demand professions, and remote patient monitoring
Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a
global leader in photonics-based health monitoring and
communications solutions, today announced that it completed an
IRB-approved human study measuring blood pressure that utilized its
non-invasive, cuffless biosensing device, currently under
development.
Based on its innovative laser-based technology, Rockley’s
powerful technique for monitoring blood pressure does not rely on
subject demographics, unlike many current cuffless blood pressure
devices.
Continuous, accurate and convenient monitoring of blood pressure
is expected to advance the early diagnosis and treatment of
hypertension, which is a risk factor for other serious health
problems, such as heart disease and stroke. The current standard of
blood pressure measurement may not provide the full picture of an
individual’s health because it is measured only periodically,
usually at a medical appointment. Even daily blood pressure
readings performed at home don’t capture enough essential
information because they do not provide frequent, trending
information or nighttime changes in blood pressure, which provide
better predictions of cardiovascular risk.
Data collected in Rockley’s proof of concept blood pressure
study provides promising results. The next phase is a
200-participant human study, beginning this fall. This study will
utilize Rockley’s next generation wearable devices and will include
isometric and aerobic exercise-based protocols. An in-line arterial
study with an accurate pressure monitoring catheter reference on 30
subjects is also planned for this fall.
In addition to medical settings, other potential applications
for non-invasive blood pressure measurement are clinical trials,
sports and athletic training and workers in physically and
mentally-demanding professions like fire fighters and construction
workers.
Dr. Andrew Rickman, chairman and chief executive officer of
Rockley said: “Blood pressure is one of the most important vital
signs and a key indicator of several serious diseases. This study
has shown promise, and I believe it demonstrates the unique
potential for our technology. Our results have been received with a
great deal of excitement from key customers.”
Zahi Fayad, Ph.D., professor of radiology and medicine
(cardiology) and Rockley scientific advisory board member, said:
“The preliminary results from this study are exciting as they
tracked well against standard cuff measurements. This technology
could potentially fill long standing gaps in providing improved
management of cardiovascular diseases.”
Results from Rockley’s blood pressure study are presented in a
new whitepaper: Intra-Subject Blood Pressure Tracking Using an
Innovative Cuffless Laser-Based Technology, available for download
on Rockley’s website.
More information about Rockley’s digital health monitoring
solution is available here:
https://rockleyphotonics.com/healthcare-sensing
About Rockley Photonics
A global leader in photonics-based health monitoring and
communications solutions, Rockley Photonics is developing a
comprehensive range of photonic integrated circuits and associated
modules, sensors, and full-stack solutions. From next-generation
sensing platforms specifically designed for mobile health
monitoring and machine vision to high-speed, high-volume solutions
for data communications, Rockley is laying the foundation for a new
generation of applications across multiple industries. Rockley
believes that photonics will eventually become as pervasive as
micro-electronics, and it has developed a platform with the power
and flexibility needed to address both mass markets and a wide
variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support
hyper-scale manufacturing and address a multitude of high-volume
markets. Rockley has partnered with numerous tier-1 customers
across a diverse range of industries to deliver the complex optical
systems required to bring transformational products to market.
To learn more about Rockley, visit rockleyphotonics.com.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release that are not historical facts
constitute “forward-looking statements” for purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements
regarding Rockley’s future expectations, beliefs, plans,
objectives, and assumptions regarding future events or performance.
The words “accelerate,” “advance,” “anticipate,” “believe,” “can,”
“capability,” “continue,” “could,” “develop,” “enable,” “estimate,”
“eventual,” “expand, “expect,” “focus,” “forward,” “future,”
“goal,” “intend,” “may,” “might,” “opportunity,” “outlook,” “plan,”
“possible,” “position,” “potential,” “predict,” “project,”
“revolutionize,” “seem,” “should,” “trend,” “vision,” “will,”
“would” or other terms that predict or indicate future events,
trends, or expectations, and similar expressions or the negative of
such expressions may identify forward-looking statements, but the
absence of these words or terms does not mean that a statement is
not forward-looking. Forward-looking statements in this press
release include, but are not limited to, statements regarding the
following: (a) whether continuous blood pressure monitoring will
advance the early diagnosis of hypertension; (b) whether Rockley’s
continuous blood pressure monitoring will provide better
predictions of cardiovascular risk than standard alternatives; (c)
the timing and anticipated parameters of the next phase of the
study; (d) the potential of our technology; (e) the submission of
study results for peer-review in an academic publication; (f) the
anticipated and potential features, scope, goals, and benefits of
the Company’s platform, products, and technology; (g) Rockley’s
development of a range of photonic integrated circuits and
associated modules, sensors, and full-stack solutions; (h)
Rockley’s belief that photonics will eventually become as pervasive
as micro-electronics; and (i) Rockley’s potential to support
hyper-scale manufacturing, address a multitude of high-volume
markets, and deliver the complex optical systems required to bring
transformational products to market.
Forward-looking statements are subject to several risks,
assumptions, and uncertainties (many of which are beyond Rockley’s
control) that may cause actual results or performance to differ
materially from those expressed or implied by these forward-looking
statements. These risks, assumptions, and uncertainties include,
but are not limited to, the factors described under the heading
“Risk Factors” in our Annual Report on Form 10-K for the year ended
December 31, 2021, and in other documents we file with the
Securities and Exchange Commission. If any of these risks or
uncertainties materialize, or should any of these assumptions prove
incorrect, actual results may differ materially from those
discussed in or implied by these forward-looking statements. There
can be no assurance that future developments affecting Rockley will
be those that have been anticipated. Given these risks and
uncertainties, you should not place undue reliance on these
forward-looking statements. These forward-looking statements speak
only as of the date hereof and Rockley does not intend to update or
revise any forward-looking statements, whether because of new
information, future events, or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221019005480/en/
Media Debra Raine Rainemakers Telephone: +1 415-349-7432 Email:
rockleyphotonics@rainemakers.com
Investors Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Jan 2025 to Feb 2025
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Feb 2024 to Feb 2025